HIV and Substance Use. Disclosure. Learning Objectives

Size: px
Start display at page:

Download "HIV and Substance Use. Disclosure. Learning Objectives"

Transcription

1 HIV and Substance Use Thomas E. Freese, Ph.D. Director, Pacific Southwest Addiction Technology Transfer Center Director of Training, UCLA Integrated Substance Abuse Programs Florida AIDS Education and Training Center May 2009 Disclosure I have no real or perceived vested interests that relate to this presentation nor do I have any relationships with pharmaceutical companies, biomedical device manufacturers, and/or other corporations whose products or services are related to pertinent therapeutic areas. Learning Objectives Identify the neurocognitive impact of substance dependence Describe the strategies for providing services to substance using clients with or at risk for HIV Identify the primary drug trends impacting clients with or at risk for HIV

2 Why do people take drugs? To feel good To have novel: Feelings Sensations Experiences AND To share them To feel better To lessen: Anxiety Worries Fears Depression Hopelessness Withdrawal A Major Reason People Take a Drug is They Like What it Does to Their Brains

3 Natural Rewards Elevate Dopamine Levels % of Basal DA Output Empty FOOD Box Feeding NAc shell Time (min) Source: Di Chiara et al. DAConcentration (% Baseline) ScrScr BasFemale 1 Present SEX Scr Sample Number Mounts Intromissions Ejaculations Source: Fiorino and Phillips Scr Female 2 Present Copulation Frequency

4 % of Basal Release Effects of Drugs on Dopamine Release Accumbens AMPHETAMINE DA DOPAC HVA hr Time After Amphetamine % of Basal Release Accumbens COCAINE DA DOPAC HVA hr Time After Cocaine % of Basal Release NICOTINE Accumbens Caudate hr Time After Nicotine Source: Di Chiara and Imperato Prolonged Drug Use Changes The Brain In Fundamental and Long-Lasting Lasting Ways We Have Evidence That These Changes Can Be Both Structural and Functional AND We Have Evidence That These Changes Can Be Both Structural and Functional

5 Normal Cocaine Abuser (10 Days) Cocaine Abuser (100 Days) Sources: Volkow, et al., Synapse, 11: , 1992 & Volkow, et al., Synapse, 14: , 1993 Dopamine D2 Receptors are Lower in Addiction Cocaine DA DA DA Meth Alcohol DA D2 Receptor Availability DA DA DA DA DA DA DA DA DA Reward Circuits Non-Drug Abuser DA DA DA DA DA DA Heroin control addicted Reward Circuits Drug Abuser Repeated drug exposure (e.g., via neurotrophic factors, FosB, CREB?) Normal responses to drugs Use-dependent plasticity leading to sensitized responses to drug and environmental cues Nestler, 2001

6 Chronic cocaine increases density of dendritic spines and neuronal branching in the nucleus accumbens Branches 50 COC 8 CTL COC CTL COC 45 CTL COC CTL Robinson, T.E. & Kolb, B. Eur. J. of Neuro Ferrario, C.R. et al. Biol. Psychiatry, Methamphetamine PET Scan of Long-Term Impact of Methamphetamine on the Brain

7 Dopamine Transporters in Methamphetamine Abusers Normal Control Methamphetamine Abuser p < Dopamine Transporter (Bmax/Kd) Dopamine Transporter Bmax/Kd Motor Activity Time Gait (seconds) Memory Delayed Recall (words remembered) Control > MA MA > Control

8 How much does the brain heal? PET Scan of Long-Term Meth Brain Damage Partial Recovery of Brain Dopamine Transporters in Methamphetamine (METH) Abuser After Protracted Abstinence 3 0 Normal Control METH Abuser (1 month detox) METH Abuser (24 months detox) ml/gm Source: Volkow, ND et al., Journal of Neuroscience 21, , 2001.

9 Methamphetamine and HIV and the Brain Meth Abuse, HIV Infection Cause Changes in Brain Structure Methamphetamine abuse and HIV infection cause significant alterations in the volume of brain gray matter structures and cognitive functions In both cases the changes may be associated with impaired cognitive functions, such as difficulties in learning new information, solving problems, maintaining attention and quickly processing information. Co-occurring methamphetamine abuse and HIV infection appears to result in greater impairment than each condition alone. SOURCE: Meth Abuse, HIV Infection Cause Changes in Brain Structure Methamphetamine abuse is associated with increases in the volume of the brain's parietal cortex (which helps people to understand and pay attention to what's going on around them) and basal ganglia (linked to motor function and motivation). HIV infection is associated with prominent volume losses in the cerebral cortex (involved in higher thought, reasoning, and memory), basal ganglia, and hippocampus (involved in memory and learning). SOURCE:

10 Meth Abuse, HIV, and Brain Volume CRACK COCAINE AND HIV Crack Cocaine and HIV Infection HIVNET: 4,892 persons at high-risk for HIV infection enrolled in cohort between Cohort incidence: 1.3 infections per 100 persons per year (ppy) MSM incidence: 2.0 per 100 ppy Definitely interested in vaccine: 2.0 per 100 ppy Female crack cocaine users: 1.6 per 100 ppy Seague et al., 2001

11 Crack Cocaine and HIV Risks HIV risk behaviors in 637 crack, powder cocaine and heroin users in central Harlem: Injectors (OR = 2.5) Engaged in fraud/cons (OR = 2.6) Separated/divorced/widowed (OR = 2.2) Multiple sex partners (OR = 1.7) Females (OR = 1.7) Davis et al., 2006 Crack Cocaine and HIV Risks for Females? Crack cocaine use causes significant problems with response to HIV treatment In 113 HIV-positive individuals in methadone maintenance, ART adherence was 46% for females; 73% for males (p<.05; Berg et al., 2004) Factors associated with worse adherence in separate gender strata were: No HIV support group (p<.0001) Crack cocaine use (p<.005) Medication side effects (p<.005) Among females, reported heavy alcohol use (p<.05) Crack Cocaine Use and HIV Disease In one study, the majority of 137 HIV-infected African American crack cocaine users reported ARV adherence 53% claim full adherence with 1 or more medications (Crisp et al., 2004) In 1,196 African American HIV-infected women, crack users (26%) were significantly less likely than non users to take ART exactly as prescribed (OR =.37; Sharpe et al., 2004) Among HIV-infected individuals, crack cocaine use (OR = 1.8) and HIV symptoms (OR = 1.7) significantly predicted progression to AIDS (Webber et al., 1999)

12 What s new and what s next Prescription Drug Abuse What is Rx & OTC Drug Misuse? Any Rx and OTC drug can be misused Misuse = Non-medical use = Any use that is outside of medically prescribed regimen Examples include: Taking for psychoactive high effects Taking for effects not indicated Taking non-medical extreme doses Mixing meds Using with alcohol or other substances Obtaining from non-medical source Obtaining from multiple sources at a time (Dr. Shopping) Should there be Concern? Populations most at risk are Youth Young Adults Older Adults

13 Rx Drug Misuse in the U.S. 6.4 million (2.6%) aged 12 or older used prescription-type drugs non-medically. Reported Non-Medical Prescription Drugs of Abuse (2005) S edatives Tranquilizers S timulants P ainkillers 4,700,000 1,800,000 1,100, ,000 NSDUH, 2006 Commonly Misused Rx Drugs Classified in 3 classes Opiates: pain-killers Eg. Vicodin, Oxycontin, Tylenol Codeine CNS Depressants (Sedatives/Tranqualizers): treat anxiety and sleep disorders Ex. Xanax, Ativan, Valium, Soma Stimulants: ADHD, weight loss Ex. Aderall, Ritalin, Concerta, Dexedrine, Fastin OTC Medicine Abuse Dextromethorphan DXM is the active ingredient in over 100 cold/cough remedies. Found in tablets, capsules, gel caps, lozenges & syrups, teens discovered: using mass quantities of DXM-containing products get them high.

14 Examples of Popular OTC Products Coricidin HBP Cough & Cold Robitussin Cough products Sudafed Cough medicines Dimetapp DM Tylenol Cold products Vicks 44 Cough Relief Vicks NyQuil and Dayquil Triaminic Cough syrups Alka-Seltzer Plus Cold & Cough Access & Availability The Home Retail Pharmacies The Internet Online Access No Prescriptio n Required!

15 Social Networking Web Sites: Medicine Abuse Subculture MySpace YouTube LiveJournal Facebook Footage of teens high User Guides: Rx & OTC abuse instructions (recipes) Blogs & videos of experiences Medicalization of Youth Behavioral Problems Direct-to-Consumer (DTC) Advertising of Psychiatric Drugs Amazon.com pushing ADHD drugs with front-page, celebrity-endorsed

16 Teens Don t Understand the Risks & Effects of Abusing Rx and OTC Medicines Over 50% believe that abusing these medicines to get high is NOT risky Join Together, 2006 Dependence & Treatment Abusing Rx drugs before the age of 16 leads to a greater risk of dependence later in life. The # of teens going into treatment for Rx drug abuse has increased by more than 300% during the last 10 years. Between , the proportion of those seeking treatment for Rx drugs increased by 9%. TEDS, 2006

17 Risk Behaviors of Youth Living with HIV: Pre/Post HAART Era Pre-HAART 349 YLH recruited mean age: % males Post-HAART 175 YLH recruited mean age: % males Sexual Behavior Pre-HAART Post-HAART Number of Partners Number Acts of UPS Percent UPS 27% 42% Source: Marguerita Lightfoot, PhD et al, American Journal of Health Behavior, 2005 Risk Behaviors of Youth Living with HIV (YLH): Pre/Post HAART Era, cont. Frequent Substance abuse Odds Ratio 95% Confidence Limits Alcohol 2.51 ( 1.71, 3.68)** Marijuana (non prescribed) 2.36 ( 1.55, 3.58)** Stimulants 2.27 ( 1.29, 3.99)** Inhalants 3.29 ( 1.06, 10.21)* Cocaine 3.06 ( 1.07, 8.75)* Crack 3.43 ( 1.22, 9.58)* Heroin 2.41 (.72, 8.00) Hard Drugs 2.80 ( 1.74, 4.49)** Note. Pre-HAART is referent group * P<.05; ** P<.01 Source: Marguerita Lightfoot, PhD et al, American Journal of Health Behavior, 2005 Older Adults

18 Alcohol Prescribed drugs Over-the-counter meds Interactions between alcohol and Rx and OTC drugs Illicit Drugs ( street ) RX Drug Abuse in Older Adults Adults 65+ represent 13% of U.S population, and account for one-third of all medications prescribed in the U.S. 21.7% (7.2 million) receive at least 1 abusable Rx annually. Men: 17.7% Women: 24.6% Older adults use Rx drugs 3 times more than the general population. On average, older persons take 4.5 medications per day. The number of older adults who abuse Rx drugs is estimated to be as high as 2.8 million. SAMHSA, 2006; NIDA, 2005 Substance Abuse and Older Adults

19 Social Isolation and Health Status Characteristic Widowed/Divorced/Separated Married Lives Alone Lives w/ Spouse Poor/Fair Health Good/Excellent Health 0 ADLs 1-2 ADLs 3-4 ADLs 5-6 ADLs Annual Prevalence of Abusable Rx E+ 24.6% 19.9% 23.8% 20.0% 34.2% 18.0% 17.1% 31.0% 39.0% 40.7% SOURCE: Simoni-Wastila et al, under review, HIV and Aging #1 People living with HIV disease are growing older. Between 1991 and 1996, the number of new AIDS cases rose twice as fast in persons 50-plus years of age than it did in persons younger than 50 (22% vs. 9%, respectively; CDC, 1998). Older adults account for up to 15% of AIDS cases nationwide. SOURCE: National Institute on Drug Abuse, HIV and Aging #2 Older adults living with HIV/AIDS have: A more severe HIV disease course and a shorter survival rate Less desirable health indices at diagnosis (e.g., lower CD4+ cell counts) Shorter AIDS-free intervals Higher number of opportunistic infections Earlier development of tumors and lesions SOURCE: National Institute on Drug Abuse,

20 HIV and Aging: A Hidden Epidemic? The aging HIV population is living longer due to the success of anti-hiv therapies Older individuals may not be perceived to be at risk for HIV infection Therefore, they are less likely to undergo HIV testing, misdiagnosis is common, and HIV is diagnosed later in the course of HIV infection Alcohol and drug abuse have been found to confound the effects of neurocognitive functioning in older HIV-positive individuals SOURCE: Casau NC. Perspective on HIV infection and ageing: emerging research on the horizon. Clinical Infectious Diseases 41: , Sexual Risk of HIV among Older Adults Assumption older adults aren't sexually active or, if they are, they know how to avoid HIV infection Older adults and their healthcare providers usually avoid discussions of sexual behaviors and substance use Older adults may be unwilling to discuss risky behaviors because of the stigma that society attaches to these behaviors Others may be in monogamous relationships with a partner who engages in risky behavior without their knowledge SOURCE: HIV and Aging, by Andrew Shippy. Summary Older adults are at risk They need careful evaluation and screening Cognitive impairment is not a normal part of aging. Careful screening should be done for substance abuse, HIV and other medical conditions. Older people have sex talk to them about it.

21 Methamphetamine and Sex Connection in Heterosexuals Q.1: My sexual thoughts, feelings, and behaviors are often associated with Percent Responding "Yes" opiates alcohol cocaine meth Primary Drug of Abuse male female Q.2: My sexual drive is increased by the use of Percent Responding "Yes" opiates alcohol cocaine meth Primary Drug of Abuse male female

22 Q.4: My sexual performance is improved by the use of Percent Responding "Yes" opiates alcohol cocaine meth male female Primary Drug of Abuse Q.10: I am more likely to have sex (e.g., intercourse, oral sex, masturbation, etc.) when using Percent Responding "Yes" opiates alcohol cocaine meth 61.1 male female Primary Drug of Abuse Q.12: I am more likely to practice risky sex under the influence of (e.g., not use condoms, be less careful about who you choose as a sex partner, etc.) Percent Responding "Yes" opiates alcohol cocaine meth male female Primary Drug of Abuse

23 Methamphetamine and HIV in MSM: Time-to to-response Association? % Percent HIV % 41% 62% 20 8% 0 Probability Sample* Recreational User** Chronic Non Treatment*** Outpatient Drug-Free**** Residential**** * Deren et al., 1998, Molitor et al., 1998; ** Reback et al., in prep, *** Reback, 1997; **** Shoptaw et al., 2002; ****VNRH, unpublished data Outpatient Treatment for Methamphetamine Abuse Investigational Medication for High Blood Pressure Blood Pressure Before Tx Tx Tx Removed Treatment Works!!!

24 Investigational Medication for Methamphetamine Use Level of Use Before Tx Tx Tx Removed Treatment Failed!!! Relapse Rates Are Similar for Drug Dependence and Other Chronic Illnesses Percent of Patients Who Relapse to 60% 30 to 50% 50 to 70% 50 to 70% Drug Type I Hypertension Dependence Diabetes Asthma Source: McLellan, A.T. etal., JAMA, Vol284(13), October 4,

25 Treatment: Medical & Behavioral Drugs Sedatives Stimulants Opioids Alcohol Medical Treatment Yes No Yes Yes Behavioral Treatment Yes Yes Yes Yes Medicines for Addiction Treatment What tools do we have? Medicines for Alcohol Disulfram (Antabuse ) Acamprosate (Campral ) Naltrexone (Revia, Depade ) Naltrexone XR Inj (Vivitrol )

26 Medicines for Opioids Methadone Buprenorphine/Naloxone or Buprenorphine Naltrexone (Revia, Depade ) Medicines for Methamphetamine and Cocaine Results from the CADDs Data System (2001) *The statewide data collection system, CADDs has information on the relative usefulness of treatment for MA users, by comparing them to cocaine users.

27 Sample Size and Early Drop Out Outpatient Treatment: MA users = 27,026 COC users = 11,160 Early Dropout: Outpatient COC admissions were slightly more likely to drop out of treatment before 30 days (25.5%) as compared to MA admissions (24.1%). P =.003 Predictors (cont ) Early dropout for both MA and COC users was associated with: 1. Being disabled 2. Chronic mental illness 3. Daily use of primary drug 4. Injection use Early dropout is less likely for those under legal supervision, older age of first use of primary substance, and older age at admission. Predictors of Retention in Treatment for more than 90 days 1. Higher rates of retention for men 2. Legal supervision increases treatment retention 3. Those who began use at an older age were retained better than those who started when younger 4. Those who are older at admission were retained better 5. Injection users were retained more poorly 6. Those with chronic mental illness were retained more poorly 7. Daily users are retained more poorly than those who use less often than daily

28 For more information, please contact Tom Freese at or or

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year

More information

ine) on (% Baseli Concentratio DA C

ine) on (% Baseli Concentratio DA C Chemical Dependency Relapse Pathways Relapse Prevention Medications Understanding the how, why, where and when. Acknowledgements La Hacienda Treatment Center American Society of Addiction Medicine National

More information

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?

More information

The Biology of Addiction

The Biology of Addiction The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with

More information

Lesson Four: Over the Counter and Prescription Drug Abuse

Lesson Four: Over the Counter and Prescription Drug Abuse Lesson Four: Over the Counter and Prescription Drug Abuse Background Emergency rooms across the country are admitting more and more youth who are overdosing on non-prescription cough and cold medicines.

More information

Brain Health and Opioid Abuse

Brain Health and Opioid Abuse 2018 Statewide Tribal Opioid Summit Brain Health and Opioid Abuse Healing From Opiate Addiction Requires Comprehensive Approaches Psychological, Socio-Cultural, and Biological Donald R. Vereen, Jr., M.D.,

More information

NATURE VS NURTURE. Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION

NATURE VS NURTURE. Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION Review of biology of addiction The Opioid Epidemic Impact on the individual Impact

More information

Addiction 101. Steve Hanson - Associate Commissioner NYS OASAS

Addiction 101. Steve Hanson - Associate Commissioner NYS OASAS Addiction 101 Steve Hanson - Associate Commissioner NYS OASAS After lunch Psychopharmacology Lecture Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like

More information

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation

More information

Medical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine

Medical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction

More information

You already know about the dangers

You already know about the dangers A Parent s Guide You already know about the dangers of illegal street drugs like marijuana, cocaine, and methamphetamine. But did you know that some teens are abusing legal products, like cough medicine,

More information

The Neurobiology of Addiction

The Neurobiology of Addiction The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly

More information

Addiction as a Neuropsychiatric Medical Condition

Addiction as a Neuropsychiatric Medical Condition Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary

More information

Prescription for Trouble

Prescription for Trouble RESOURCE GUIDE Parents & Kids Grades 6-12 for parents & kids Prescription for Trouble by CWK Network, Inc. # 5285 The sub-culture of drug use in America has evolved, and now there is a new threat to our

More information

OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER

OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER Ed Johnson M.Ed., MAC, LPC, CCS Associate Director, Training & Technical Assistance Southeast Addiction Technology Transfer Center

More information

Methamphetamine 101. A history and overview of Meth

Methamphetamine 101. A history and overview of Meth Methamphetamine 101 A history and overview of Meth What is Methamphetamine? Crystal Methamphetamine is a chemical that has stimulant properties and is highly addictive. What Meth does to the Brain % of

More information

The Neurobiology of Drug Addiction

The Neurobiology of Drug Addiction The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology and Toxicology, U of U Senior Advisor, NIDA Drug Abuse and Addiction are Among

More information

Neurobiology of Addiction

Neurobiology of Addiction Neurobiology of Addiction Cindy Miner, Ph.D. Deputy Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health Department of Health and Human Services

More information

Co-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking

Co-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking Co-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking Sherry Larkins, Ph.D UCLA Integrated Substance Abuse Program June 24, 2011 1 Roadmap Overview of Co-Occurring Disorders

More information

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?

More information

NIDA Quick Screen V1.0F1

NIDA Quick Screen V1.0F1 NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

Implementing Adolescent Recovery Supports & Developing Resources in our Communities

Implementing Adolescent Recovery Supports & Developing Resources in our Communities Implementing Adolescent Recovery Supports & Developing Resources in our Communities Reclaiming Futures Thursday, September 27th 11am PDT / 2pm EDT Click to edit Master title style Common Myths About Drug

More information

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:

More information

Methods for Identifying Street & Prescription Drug Abuse

Methods for Identifying Street & Prescription Drug Abuse Methods for Identifying Street & Prescription Drug Abuse presented by Sharon S. Kelley, MS, PhD Chief Executive Officer Associates In Emergency Medical Education, Inc. Alliance for Global Narcotics Training,

More information

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained

More information

Addressing Opiate Abuse

Addressing Opiate Abuse Addressing Opiate Abuse William B. Lawson, MD, PhD, DLFAPA Associate Dean of Health Disparities University of Texas at Austin Dell Medical School william.lawson@austin.utexas.edu Opioids Medications that

More information

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas Eighth Edition Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas 1 < < < Evolution of our Human Brain: Spinal Cord to Diencephalon to Mammalian-Meso Cortex to Neo Cortex

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

Prescription for Trouble

Prescription for Trouble Pharm Parties (fär m pär tes) pharm is short for pharmaceutical. A social gathering where everyone brings some kind of prescription or over-the-counter drug to share like a pharmaceutical cocktail party.

More information

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been

More information

NIDA-Modified ASSIST Prescreen V1.0 1

NIDA-Modified ASSIST Prescreen V1.0 1 NIDA-Modified ASSIST Prescreen V1.0 1 F Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to

More information

Medication Assisted Treatment (MAT): A Component of Comprehensive Treatment for Substance Use Disorders

Medication Assisted Treatment (MAT): A Component of Comprehensive Treatment for Substance Use Disorders Medication Assisted Treatment (MAT): A Component of Comprehensive Treatment for Substance Use Disorders Tennessee Substance Exposed Infants (SEI) Neonatal Abstinence Syndrome (NAS) Workgroup Nancy K. Young,

More information

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)

More information

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Restoration of Parenting Ability Through Treatment for Substance Use Disorders Restoration of Parenting Ability Through Treatment for Substance Use Disorders DEBRA M. BARNETT, MD Board Certified in General Psychiatry, Addiction Psychiatry, Geriatric Psychiatry, and Forensic Psychiatry

More information

Understanding Drug Abuse and Addiction. Steve Hanson - Associate Commissioner NYS OASAS

Understanding Drug Abuse and Addiction. Steve Hanson - Associate Commissioner NYS OASAS Understanding Drug Abuse and Addiction Steve Hanson - Associate Commissioner NYS OASAS Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like Drugs. 2. We all

More information

Methamphetamine Creighton University

Methamphetamine Creighton University Methamphetamine Creighton University Eugene J. Barone, M.D. * Syed Pirzada Sattar, M.D. Kathryn N. Huggett, Ph.D. * Amanda S. Lofgreen, M.S. These curriculum resources from the NIDA Centers of Excellence

More information

Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director

Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director @NIDAnews Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions % of Basal

More information

THE STATE OF MEDICINE IN ADDICTION RECOVERY

THE STATE OF MEDICINE IN ADDICTION RECOVERY OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,

More information

OPIATE ABUSE WEBCAST October 16, 2014

OPIATE ABUSE WEBCAST October 16, 2014 OPIATE ABUSE WEBCAST October 16, 2014 TABLE OF CONTENTS Program Graphics Pg 1 References 23 Level II Evaluation 26 Questions I Have form 27 Learning Objectives: After participating in today s training,

More information

Addiction, the Brain and Recovery

Addiction, the Brain and Recovery Addiction, the Brain and Recovery The Neuroscience of Addiction Opioid Substitution Therapy Conference Saskatoon, SK April 29, 217 Gerald Block, Ph.D. Registered Doctoral Psychologist Calder Centre Saskatoon

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

Preventing Teen Cough Medicine Abuse

Preventing Teen Cough Medicine Abuse Preventing Teen Cough Medicine Abuse Teen Cough Medicine Abuse: A Wake-Up Call More than one in three American high school teens know someone who has abused cough medicine according to the Partnership

More information

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

Child Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network

Child Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network Child Welfare and Substance Abuse Erica Tarasovitch, MSW Central Florida Behavioral Health Network Parental Substance Use Marijuana was the most commonly used illicit drug in 2006, accounting for 72.8

More information

Prescription Opioids: What HIV Clinicians Need to Know TRAINER S NAME TRAINING DATE TRAINING LOCATION

Prescription Opioids: What HIV Clinicians Need to Know TRAINER S NAME TRAINING DATE TRAINING LOCATION Prescription Opioids: What HIV Clinicians Need to Know TRAINER S NAME TRAINING DATE TRAINING LOCATION Training Collaborators Pacific AIDS Education and Training Center Charles R. Drew University of Medicine

More information

Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director

Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director @NInews Concentration ) Dopamine (nm) Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions

More information

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type pain

More information

Popping Pills for Thrills Implications for preventing the misuse of pharmaceuticals

Popping Pills for Thrills Implications for preventing the misuse of pharmaceuticals Popping Pills for Thrills Implications for preventing the misuse of pharmaceuticals Carla Janáe Brown, M.S. Many Voices, One Vision Conference: Achieving Our Vision through Collaboration August 1, 2007

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

Drugs, Brain and Behavior

Drugs, Brain and Behavior Drugs, Brain and Behavior The Neuroscience of Addiction and Trauma Libby Stuyt, MD NADA Training September 2015 Why Do People Try Alcohol, Tobacco, or Drugs in the First Place? Parents/family members use

More information

Prolonged Use Changes the brain in Fundamental and Long Lasting Ways. People like Drugs. We all like things faster and easier.

Prolonged Use Changes the brain in Fundamental and Long Lasting Ways. People like Drugs. We all like things faster and easier. Understanding Drug Abuse and Addiction Basic Questions Steve Hanson Why do people do drugs? Why can t/ won t some people stop? People like Drugs. We all like things faster and easier. Realities How Drugs

More information

The Science of Drug Addiction: Implications for Clinical Practice

The Science of Drug Addiction: Implications for Clinical Practice The Science of Drug Addiction: Implications for Clinical Practice Jack B. Stein, Ph.D. Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health

More information

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016 1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

The Importance of Psychological Treatment and Behavioral Support

The Importance of Psychological Treatment and Behavioral Support The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding

More information

Patient Care Planning Group April 3, 2014

Patient Care Planning Group April 3, 2014 Patient Care Planning Group April 3, 2014 Philip O. Toal, Ed.D,; LMHC, CET Administrator, Non-Residential Services The Center For Drug Free Living, a founding partner of Aspire Health Partners Participants

More information

Improving the Arizona HIV Care Continuum: Focus on Linkage

Improving the Arizona HIV Care Continuum: Focus on Linkage Improving the Arizona HIV Care Continuum: Focus on Linkage An Interactive Approach Using Cases Tom Donohoe Professor of Family Medicine Director, Los Angeles Region AIDS Education and Training Center Associate

More information

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre 1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement

More information

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Opioid Withdrawal, Opioid Substitution, and HIV Infection Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending

More information

NIDA Research. Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment

NIDA Research. Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment Timothy P. Condon, Ph.D. Deputy Director National Institute on Drug Abuse National Institutes of Health Department of Health and

More information

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER

More information

OPIOID ADDICTION AND THE BRAIN MICHAEL NERNEY AND ASSOCIATES P.O. BOX 93 LONG LAKE, NY

OPIOID ADDICTION AND THE BRAIN MICHAEL NERNEY AND ASSOCIATES P.O. BOX 93 LONG LAKE, NY OPIOID ADDICTION AND THE BRAIN MICHAEL NERNEY AND ASSOCIATES P.O. BOX 93 LONG LAKE, NY 12847-0093 518-624-5351 MCNERNEYLL@FRONTIERNET.NET A DISEASE OF THE BRAIN ASAM Primary chronic disease of the brain

More information

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, M.D. Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated

More information

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Opioid Pain Contracts: A Resident Driven Quality Improvement Project Opioid Pain Contracts: A Resident Driven Quality Improvement Project A Response to the Opioid Epidemic Dr. Phillip Knouse Dr. Victoria Montgomery Disclosure None Objectives Discuss the current Opioid Epidemic

More information

Discover the Hope: Opiate Treatment and Recovery

Discover the Hope: Opiate Treatment and Recovery Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of

More information

Substance Abuse Protracted Withdrawal

Substance Abuse Protracted Withdrawal Substance Abuse Protracted Withdrawal Overview 1. Acute and Protracted Withdrawal 2. Withdrawal Potential Kate Speck, PhD, MAC, LADC 3. Recovery Reinforcers 1 2 3 Addiction Addiction is a primary, chronic,

More information

NIDA-Modified ASSIST - Prescreen V1.0*

NIDA-Modified ASSIST - Prescreen V1.0* NIDA-Modified ASSIST Assessment Instrument [1] NIDA-Modified ASSIST - Prescreen V1.0* *This screening tool was adapted from the WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Version

More information

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age. 1 Chapter 12 Section 1 Objectives List six ways illegal drug use can be dangerous. State five reasons a person might try illegal drugs. Identify the reason drug abuse is especially dangerous to teens.

More information

The Science of Addiction: Prescription Opioid Abuse. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

The Science of Addiction: Prescription Opioid Abuse. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse The Science of Addiction: Prescription Opioid Abuse Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Key Points: 1. Prescription opioid abuse is a major problem in USA

More information

In the Doctor s Office

In the Doctor s Office In the Doctor s Office Recovery Friend or Foe? 1 Recovery ally? Recovery ally? Relapse waiting to happen? The National Picture 2 First Time Use 2013 NSDUH Treatment for Pain Relievers 2002-2013 NSDUH 3

More information

[ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] Macomb County Office of Substance Abuse. A Focus on Heroin and Prescription Drug Abuse

[ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] Macomb County Office of Substance Abuse. A Focus on Heroin and Prescription Drug Abuse 2010 Macomb County Office of Substance Abuse Planning Contracting Monitoring [ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] A Focus on Heroin and Prescription Drug Abuse 22550 Hall Road Clinton

More information

The Neuroscience of Addiction: A mini-review

The Neuroscience of Addiction: A mini-review The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship

More information

8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy

8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days

More information

Opioid Epidemic Update

Opioid Epidemic Update Opioid Epidemic Update - 2018 Talal Khan MD Addiction Psychiatrist Pine Rest What are Opioids? Opiates are alkaloid compounds naturally found in the opium Poppy plant. Papaver somniferum The psychoactive

More information

Drug Trends &Trafficking I/S Brian Dempsey

Drug Trends &Trafficking I/S Brian Dempsey Drug Trends &Trafficking I/S Brian Dempsey 412-777-6945 brian.w.dempsey@usdoj.gov Sources Sources 360 Degree Strategy Strategic collaboration and guidance via three interconnected avenues. Community

More information

Medication for Addiction Treatment (MAT)

Medication for Addiction Treatment (MAT) SBIRT Training Screening, Brief Intervention & Referral to Treatment Medication for Addiction Treatment (MAT) The Faith & Spirituality Integrated SBIRT Network Navigating the Training Welcome! These health

More information

Steve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services

Steve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services Understanding Alcohol Abuse and Addiction Steve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services Steve.hanson@oasas.state.ny.us Agenda Understanding Alcohol/Drug

More information

Methamphetamine and HIV: What Border Providers Need to Know May 23, 2016 Yuma, Arizona

Methamphetamine and HIV: What Border Providers Need to Know May 23, 2016 Yuma, Arizona Methamphetamine and HIV: What Border Providers Need to Know May 23, 2016 Yuma, Arizona Tom Donohoe tdonohoe@mednet.ucla.edu Associate Professor of Family Medicine Director, Los Angeles Region Pacific AIDS

More information

Youth, Opioid Use and Treatment Options. CPSO MMT Providers Conference Dr. Sharon Cirone MD FCFPC November 2016

Youth, Opioid Use and Treatment Options. CPSO MMT Providers Conference Dr. Sharon Cirone MD FCFPC November 2016 Youth, Opioid Use and Treatment Options CPSO MMT Providers Conference Dr. Sharon Cirone MD FCFPC November 2016 Disclosures No propriety involvement in pharmaceutical companies Assessor, CPSO Methadone

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

Opioid Use and Other Trends

Opioid Use and Other Trends Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current

More information

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

*IN10 BIOPSYCHOSOCIAL ASSESSMENT* BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding

More information

NOW CANADA SOCIETY TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) FAX (250)

NOW CANADA SOCIETY TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) FAX (250) NOW CANADA SOCIETY 2970 TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) 763-3876 FAX (250) 868-3876 EMAIL support@nowcanada.ca RESIDENTIAL / DAY PROGRAM REFERRAL PACKAGE THE NOW CANADA SOCIETY MISSION

More information

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM Preventative Education: Substance Use Disorder Misuse of prescription pain relievers is, after marijuana use, the second most common form of

More information

Teen drug use continues down in 2006, particularly among older teens; but use of prescription-type drugs remains high

Teen drug use continues down in 2006, particularly among older teens; but use of prescription-type drugs remains high December 21, 2006 Contacts: Joe Serwach, (734) 647-1844 or jserwach@umich.edu Patti Meyer, (734) 647-1083 or mtfinfo@isr.umich.edu Study Web site: www.monitoringthefuture.org EMBARGOED FOR RELEASE AT 10

More information

Understanding Addiction: Why Can t Those Affected Just Say No?

Understanding Addiction: Why Can t Those Affected Just Say No? Understanding Addiction: Why Can t Those Affected Just Say No? 1 The Stigma of Addiction There continues to be a stigma surrounding addiction even among health care workers. Consider the negative opinions

More information

Brain, Pain, Opioids. John Hart, DO

Brain, Pain, Opioids. John Hart, DO Brain, Pain, Opioids CHANGE John Hart, DO 4 % Rule 1 UDS Pain score Contract & PMP Ask about addiction Ak Ask about tfunction As long as function increases, there is no upper limit to opioid UDS Pain

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Update on Medications for Tobacco Cessation

Update on Medications for Tobacco Cessation Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

Substance Use Disorders in Primary Care

Substance Use Disorders in Primary Care Substance Use Disorders in Primary Care Jin Hee Yoon-Hudman, MD Assistant Vice President, Medical Director, Behavioral Health Healthfirst Fall Symposium Prevention as a Priority in Value-Based Healthcare,

More information

TELEPHONE SCREENING DEMOGRAPHIC INFO

TELEPHONE SCREENING DEMOGRAPHIC INFO TELEPHONE SCREENING Provider Name: Provider Signature: Date: How did you hear about the hotline? DEMOGRAPHIC INFO 1 = Spouse 2 = Friend 3 = Medical Provider 4 = Flyer 5 = Parent 6 = State Hotline 7 = Physician

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

The Science of Addiction

The Science of Addiction The Science of Addiction Immersion Training in Addiction Medicine Program 2018 April 23, 2018 Daniel P. Alford, MD, MPH Professor of Medicine Associate Dean, Continuing Medical Education Director, Clinical

More information

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction

More information

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco Pharmacotherapy for opioid addiction Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco Disclosure slide No commercial conflicts to disclose. Gaps in current treatment of opioid

More information

III. FREQUENTLY ASKED QUESTIONS

III. FREQUENTLY ASKED QUESTIONS III. FREQUENTLY ASKED QUESTIONS 1. Why do adolescents take drugs? Adolescents experiment with drugs or continue taking them for several reasons, including: To fit in: Many teens use drugs because others

More information

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018 Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral

More information